Joint Venture26 Mar 2026, 06:01 pm
Privi Speciality Chemicals Subscribes to Equity Share Capital in Joint Venture Company Prigiv Specialties
AI Summary
Privi Speciality Chemicals Ltd has subscribed towards the equity share capital in the joint venture company, Prigiv Specialties Private Limited. This is in accordance with the Joint Venture Agreement and Amendment Agreements entered into with Givaudan SA, Switzerland. The Board of Directors of Prigiv Specialties Private Limited had approved the circular resolution for the allotment of Equity Share Capital on March 26, 2026. The Paid-up Capital of the Joint Venture Company post-allotment is as follows: Privi Speciality Chemicals Limited: INR 2,55,00,000 (49%), Givaudan SA, Switzerland: INR 2,45,00,000 (51%).
Key Highlights
- Privi Speciality Chemicals Ltd and Givaudan SA, Switzerland enter into a Joint Venture Agreement
- Both parties have subscribed to the Equity Share Capital of Prigiv Specialties Private Limited
- The Board of Directors of Prigiv Specialties Private Limited has approved the allotment of Equity Share Capital
- Post-allotment, the Paid-up Capital of the Joint Venture Company is INR 5,00,00,000
- Privi Speciality Chemicals Ltd holds 49% and Givaudan SA, Switzerland holds 51% of the Paid-up Capital